Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

Geetanjali Dang; Ryan Grayburn; Geoffrey Lamb; Adrian Umpierrez De Reguero; Nunzio Gaglianello

doi:10.1155/2014/826453

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

Case Rep Cardiol. 2014:2014:826453. doi: 10.1155/2014/826453. Epub 2014 Dec 18.

Authors

Geetanjali Dang¹, Ryan Grayburn², Geoffrey Lamb¹, Adrian Umpierrez De Reguero¹, Nunzio Gaglianello²

Affiliations

¹ Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
² Advanced Heart Failure and Transplant Cardiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Abstract

HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients. These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding. The data for the management of patients with LVAD presenting with GI bleeding is limited. We describe a 56-year-old lady, recipient of a HeartWare device, who experienced recurrent GI bleeding and was successfully managed with subcutaneous (SC) formulations of octreotide.